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The growth of intellectual property as a consequence of scientific and 
technological advancement has given rise to complex relationships among 
the various forms of intellectual property rights.  As different forms of 
intellectual property rights have expanded, some have moved toward 
protecting the same or similar subject matters.  Such is the case with patent 
and plant variety protection, which have experienced a growing overlap.  
This overlap can affect the right holders if the effective exploitation of a 
patent cannot be made without infringement of the plant breeders’ rights 
and vice versa.  Moreover, the possible overlap may adversely affect the 
interests of farmers, because patent protection does not recognize the 
farmers’ privilege, typically granted by plant variety protection, to save and 
exchange seeds. 
Plant variety protection has become an important issue since the 
adoption of the TRIPS Agreement on intellectual property rights in 1994.  
However, it remains a novelty for all but a few African countries, and 
constitutes a significant departure from the customary practice based on the 
free sharing of knowledge.
1
  The TRIPS Agreement generally provides for 
the patentability of inventions in all fields of technology, and specifically 
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calls for “protection of plant varieties either by patents or by an effective 
sui generis system or by any combination thereof.”
2
  Member states of the 
TRIPS Agreement from Africa are under an obligation to comply with this 
mandate, though they may take any approach they wish.  The most 
common means of implementation throughout the continent has been the 
adoption of the International Convention for the Protection of New 
Varieties of Plants (UPOV Convention), rather than “devising an 
alternative to monopoly rights.”
3
  
So far, there is no uniform approach in the treatment of the possible 
overlap between patents and plant variety protection.  In Africa, the 
relevant regional intellectual property organizations—the African 
Intellectual Property Organization (“OAPI”) and the African Regional 
Intellectual Property Organization (“ARIPO”)—have adopted different 
approaches.  OAPI deals directly with plant variety protection, requiring 
members’ adherence to the 1991 version of the UPOV Convention, while 
ARIPO has not specifically addressed the issue of plant variety protection.
4
  
The African Union’s model law dealing with access to biological resources 
and the rights of farmers and breeders rejects patents on life forms and 
“exclusive appropriation of any life form, including derivatives.”
5
  
Unsurprisingly, different African countries employ diverse approaches to 
the relationship between patents and plant variety protection. 
  
II. Approaches to the Protection of Plant Varieties 
 
A. The Approach in South Africa 
 
South Africa is one of the few African countries that had a plant 
variety protection regime in place prior to the adoption of the TRIPS 
Agreement.
6
  As a member of both the TRIPS Agreement and the UPOV 
Convention, South Africa has taken legislative measures to protect plant 
varieties in addition to protection of patents.  Accordingly, the Plant 
 
 2. Agreement on Trade-Related Aspects of Intellectual Property Rights art. 27.3(b), 
Apr. 15, 1994, Marrakesh Agreement Establishing the World Trade Organization, Annex 
1C, 1869 U.N.T.S. 299. 
 3. Cullet, supra note 1, at 102. 
 4. Id. at 103. 
 5. Id. See also Org. of African Unity, African Model Legislation for the Protection of 
the Rights of Local Communities, Farmers and Breeders, and for the Regulation of Access 
to Biological Resources (2000), available at http://www.opbw.org/nat_imp/model_laws/ 
oau-model-law.pdf. 
 6. Cullet, supra note 1, at 104. 
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Breeders’ Rights Act provides for protection of new varieties of plants, 
both conventionally bred and genetically modified.
7
  However, the Patents 
Act excludes patents for both plant and animal varieties.
8
  This exclusion 
does not extend to a variety developed through a microbiological process,
9
 
such as plants modified through genetic engineering.
10
  Such a process, 
carried out with human intervention, is not considered to be an “essentially 
biological process,” so its product could be the subject of both a patent and 
plant breeders’ rights under the respective legislations.
11
  This is also 
evident from the Genetically Modified Organisms Act of 1997.
12
  
Apart from its legal regimes for the protection of plant varieties and 
patents, the country has also introduced the South African Biodiversity Act 
of 2004 in order to comply with its obligation under the 1992 Convention 
on Biological Diversity (“CBD”), to which it is a signatory.
13
  The Act 
provides a benefit-sharing mechanism under which a patent holder must 
ensure compensation to a person allowing access to an indigenous 
biological resource.
14
  This act, in contrast to the aforementioned Patents 
Act, seemingly implies the possible grant of a patent over biological plant 
material, which may still involve some aspects of a plant variety.  
Moreover, the grant of plant breeders’ rights over the biological material is 
not excluded, implying a possible interface between the two systems of 
protection.  This implication was confirmed by the 2005 amendment to the 
Patents Act, at least with regard to the protection of genetic resources.
15
  
The benefit-sharing mechanism functions to regulate the possible 
competing interests of right holders and the community with a vested 
 
 7. Plant Breeders’ Rights Act 15 of 1976 (amended 1980, 1981, 1983, 1986, 1996) (S. 
Afr.). 
 8. See Patents Act 57 of 1978 s. 25(4)(b) (amended 1979, 1983, 1986, 1988, 1996, 
1997, 2001, 2002) (S. Afr.). 
 9. Id. 
 10. Genetic engineering is the process of inserting genetic information into the genomes 
of different plants; the traits or characteristics associated with the genes will be expressed in 
the plants. See ROBYN MERRY, GENETICALLY MODIFIED PLANTS: MAKING DUAL PROTECTION 
A PRIORITY (2009), available at http://www.bowman.co.za/LawArticles/Law-Article~ 
id~2132417435.asp. 
 11. Id.  
 12. Id.  
 13. David Kaplan, Intellectual Property Rights and Innovation in South Africa: A 
Framework, in THE ECONOMICS OF INTELLECTUAL PROPERTY IN SOUTH AFRICA 1, 14 (2009) 
 14. Id. 
 15. See Patents Amendment Act 20 of 2005 s. 2 (S. Afr.) (indicating the possible grant 
of a patent on an invention “based on or derived from” genetic or biological resources). It is 
possible that a genetic resource (particularly a genetically modified one) to which a patent 
pertains may involve a plant variety developed through microbiological process. 
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interest in the genetic resource, but there exists no explicit approach for 
resolving the possible conflict between the holders of different intellectual 
property rights over the biological material.  The benefit-sharing approach 
also fails to regulate cases where the interest of the users other than the 
community may be affected due to the overlap.  Hence, the competing 
interests at stake are not only that of the respective right holders but also of 
the users. 
 
B. The Approach in Ethiopia 
 
Ethiopia is not a party to the TRIPS Agreement and is currently under 
no obligation to comply with its provisions, despite the country’s 
application for accession to the WTO in 2003.  Nevertheless, Ethiopia 
introduced legal regimes for the protection of patents and plant varieties in 
1995 and 2005, respectively.
16
  Moreover, Ethiopia has ratified the African 
Union Model Law and the 1992 Convention on Biological Diversity 
(“CBD”), both of which deal with some aspects of plant variety in different 
contexts.
17
  It is important not to overlook the relevance of these legal 
regimes for the protection of plant varieties, which are a subset of the 
broader concept of all biological resources.
18
 
Ethiopia’s Patent Proclamation categorically excludes from 
patentability all plant varieties “or essentially biological processes for the 
production of plants.”
19
  In so doing, the Proclamation theoretically avoids 
the possible extension of patent rights into the realm of plant variety 
protection.  Furthermore, the law that protects plant varieties (under a sui 
generis system) does not explicitly indicate any possible relationship with 
the protection of patents under the patent legislation.
20
  In this regard, the 
 
 16. A Proclamation Concerning Inventions, Minor Inventions and Industrial Designs 
Proc. No. 123/1995, NEGARIT GAZETA OF THE TRANSITIONAL GOVERNMENT OF ETHIOPIA 
[hereinafter Patent Proc.]; Plant Breeders‘ Right Proc. No. 481/2005, FEDERAL NEGARIT 
GAZETA [hereinafter Plant Breeders’ Proc.]. 
 17. Ethiopia ratified the CBD on July 4, 1994, and UPOV on October 2, 2005. The 
country has also ratified the International Treaty on Plant Genetic Resources for Food and 
Agriculture (2001).  
 18. Cullet, supra note 1, at 122. 
 19. Patent Proc., supra note 16, art. 4(1)(b). According to European law, “A process for 
the production of plants is essentially biological if it consists entirely of natural phenomena 
such as crossing or selection.” Council Directive 98/44/EC, art. 2(2), The Legal Protection 
of Biotechnological Inventions, 1998 O.J. (L 213) 13 (EC) [hereinafter Biotech Directive]. 
 20. See Plant Breeders’ Proc., supra note 16. The provisions of the legislation reveal the 
protection of plant breeders’ rights without any explicit mention of patent rights.  This 
indicates the exclusive treatment of issues of plant variety protection, which is excluded 
from the scope of patentable inventions under the patent legislation. 
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issues of patent and plant variety protection are apparently regulated by two 
different, exclusive legal regimes.  However, like its South African 
counterpart, the Ethiopian patent law’s plant exclusion does not include 
micro-organisms and plant varieties produced through nonbiological or 
microbiological processes.
21
  Thus, genetically modified plants produced 
through a microbiological process may be subject to dual protection under 
patent and plant variety legislation.
22
 
In addition, the Proclamation on Access to Genetic Resources and 
Community Knowledge (implementing the CBD and other related 
treaties)
23
 provides for the possible grant of a patent on protected biological 
resources, subject to authorization from the concerned authority and the 
sharing of benefits.
24
  This envisages the possibility of overlapping rights, 
with a possible relationship between patent and plant variety in the context 
of protection of biological resources under a separate legislation.  The 
rights may be created in particular over “derivative” biological materials, 
defined by the legislation to include plant varieties, chemicals, and 
proteins.
25
  This suggests the possibility of both rights in the same 
derivative biological material, a situation apparently inconsistent with the 
exclusion under the patent legislation.  However, the possibility is tenable 
only if the biological material exclusively or substantially constitutes a 
plant variety, which as such is not subject to utility patent protection.  In 
other words, there is no categorical exclusion of the concurrent existence of 
patent and plant breeders’ rights over the same biological material as long 
as the respective legal requirements are met.  The question, then, is how the 
exploitation of the different rights (with different scopes of protection) can 
be regulated.  
 
 21. Unlike the corresponding provisions of the South African Patent Act, which are a 
verbatim copy of Article 27(3)(b) of the TRIPS Agreement, article 4(1)(b) of the Ethiopian 
Patent Proclamation does not expressly include or exclude the exceptions concerning micro-
organisms or nonbiological and microbiological processes for the production of plants or 
animals.  As long as they are not expressly excluded, they may be subject to patent rights 
and plant variety protection, despite the argument that the exclusion of plant variety may 
embrace micro-organisms as well.  Moreover, the total exclusion from patent protection of 
micro-organisms or plants produced through microbiological or nonbiological processes is 
inconsistent with the TRIPS Agreement.  Ethiopia will be required to remove the 
inconsistency following the finalization of its accession to the WTO. 
 22. See MERRY, supra note 10.  
 23. The relevant treaties ratified by Ethiopia include the International Treaty on Plant 
Genetic Resources for Food and Agriculture (ratified June 29, 2004); the Agreement for the 
Establishment of the Global Crop Diversity Trust (July 15, 2004); and the Cartagena 
Protocol on Biosafety (October 21, 2004). 
 24. Access to Genetic Resources and Community Knowledge, and Community Rights 
Proc. No. 482/2006, FEDERAL NEGARIT GAZETA, art. 17(12-15). 
 25. Id. art. 2(3). 
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There exists no single provision in the relevant laws that addresses this 
issue even implicitly.  As the law stands now, it arguably appears that 
Ethiopia has adopted a “dual approach” in addressing the possible 
relationship between patent and plant variety protection over the same 
biological material.  That is, both patent and plant breeders’ rights can be 
concurrently created over the same subject matter even if plant variety 
protection as such is excluded from the patent law regime.  However, this 
possible overlap is left ungoverned.  The issue may be contractually 
resolved between the right holders when it arises, but the contractual 
approach may fail to solve the problem if an agreement cannot be reached.  
This will hinder the effective exploitation of the respective rights by the 
right holders, which may result in costly litigation. It can also erode the 
incentives for innovation.  
The concern may be even more critical where the possible overlap 
tends to limit the farmers’ privilege under plant variety protection.  The 
current law for plant variety protection explicitly provides a farmers’ 
exemption, which encompasses the right to use, save, sell, and exchange 
the protected variety or propagating material
26
 without paying 
compensation to the plant breeders.  The only limitation to the exemption is 
that “farmers cannot sell farm-saved seed or propagating material . . . on [a] 
commercial scale.”
27
  Patent protection, unlike plant variety protection, 
does not contain a farmers’ exemption. 
Even though one may question the practical relevance of the issue 
from the current economic perspective of Ethiopia, it is likely to pose a 
challenge in the future.  The relevant laws need to be proactive enough to 
accommodate future developments in the seed and biotechnology 
industries,
28
 and to ensure predictability and legal certainty in order to 
 
 26. See Plant Breeders’ Proc., supra note 16, art. 6. 
 27. Id. art. 6(2). 
 28. The seed industry in Ethiopia is currently at its infant stage compared to those in the 
developed countries.  The public Ethiopian Seed Enterprise “was virtually the sole producer 
of seeds in the formal seed sector” until 1990.  Getenet Gebeyehu, General Manager, 
National Seed Industry Agency, Ethiopia, Keynote Address at the Workshop on Finance and 
Management of Small-Scale Seed Enterprises: The Role of Seed in Agriculture 3 (Oct. 26-
30, 1998). The first National Seed Industry Policy (NSIP), announced in 1992, was followed 
by the establishment of the National Seed Industry Agency in 1993 and the enactment of 
seed legislation in 1997.  The legislation “aims at regulating activities of the seed industry 
by protecting the interests of plant breeders, distributors and farmers.” Id. at 3-4. The 
government plays an active role in ensuring quality control for the seeds released to farmers. 
Id. at 4.  
Regarding the biotechnology industry, there are only a few patents which have been granted 
in Ethiopia since the enactment of the patent law in 1995, and almost all of the patents 
owned by foreigners are unrelated to biotechnological inventions.  However, this trend does 
not rule out future developments, especially with regard to protection of genetic resources in 
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promote investment in these areas.  At present, Ethiopia has no developed 
seed or biotechnology industries as such that compete for plant variety and 
patent protection on food crops.
29
  However, some cases involving food 
crops such as teff and barley have been recently identified indicating claims 
for protection by foreign companies.
30
  These crops are extremely vital 
food sources in Ethiopia, and the grant of a patent over any gene forming 
part of the varieties would limit farmers’ access to the seeds.  Moreover, 
there is increasing foreign and domestic investment in the production of 
cash crops such as flowers, cotton, and fruits.  It is thus possible that these 
agricultural products may be subject to various intellectual property rights, 
including patent and plant variety. 
 
III. The “Interface Problem” and Possible Alternatives 
 
A. The Interface Between Patents and Plant Variety Protection 
 
Despite the existence of separate legal regimes for patent and plant 
variety protection in most countries, there remains a delicate issue of 
interface, mainly due to the absence of a clear delineation between the 
scopes of the relevant laws.  This interface is evident from the approaches 
adopted by some jurisdictions.  For instance, in the European Union, 
despite a directive on the protection of biotechnological inventions and the 
European Patent Convention (“EPC”), which theoretically exclude possible 
overlap, recent case law developed by the European Patent Office (“EPO”) 
has confirmed a grant of patent over a claim consisting of plant varieties 
where no specific plant varieties were individually claimed.
31
  In the U.S., 
where plant patents are common in addition to plant variety protection, it is 
even more common than in other countries that a utility patent may 
 
Ethiopia.  At present, biotechnology research and development in Ethiopia appears to be 
negligible, and is largely confined to some governmental agencies, research institutions, and 
universities. 
 29. Most of the plant varieties identified in Ethiopia are largely the outcome of research 
conducted by a few research and academic institutions. 
 30. See generally GETACHEW MENGISTE, AFRICAN CTR. FOR TECH. STUDIES, 
BIOPROSPECTING IN ETHIOPIA: ENHANCING SCIENTIFIC AND TECHNOLOGICAL CAPACITY 
(2001). 
 31. The Enlarged Board of Appeal of EPO, in its decision on the Novartis case, has 
made clear the conformity of the new Rule 23c(b) EPC with Article 53(b) of the EPC, 
thereby indicating possible patentability of genetic inventions in animals and plants. See 
Joseph Straus, Biotechnology and Patents, 54 CHIMIA INT’L J. CHEMISTRY 293, 297 
(2000).  
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embrace a plant variety, thereby giving rise to an interface problem.
32
  
The concurrent existence of two different rights over the same subject 
matter can pose challenges to the exploitation of the rights by the 
proprietors and the interests of users, given the temporary monopoly 
conferred by the systems.  The overlap between the rights can lead to 
infringement suits between the different right holders or between right 
holders and users.
33
  A conflict of the latter sort led to a recent case in 
Canada in which Monsanto, a multinational agricultural biotechnology 
company, filed suit against a farmer for infringement of its patent on 
glyphosate-resistant plant cells and genes, due to the farmer’s use of seed 
containing the patented element.
34
  Such conflicts may be especially 
problematic in Africa, where intellectual property systems are less 
developed and efficient than in the West.  
Conflicts may also occur when plant variety protection is obtained 
over a plant variety and a patent is also granted over a certain genetic 
ingredient or biological material that forms part of the protected variety.  
For example, a biological material produced by an isolated and purified 
plant gene falls within the domain of patent protection as long as the 
isolated gene has a specific function worthy of protection.
35
  Subsequently, 
the isolated plant gene may be inserted via recombinant DNA technology 
into a targeted plant, creating a new plant variety.
36
  This new plant variety 
may thus incorporate patented biological material or involve the use of a 
patented technique,
37
 creating an overlap between the patents involved and 
protection for the new plant variety. 
Due to the different scopes of the rights,
38
 the exploitation of such 
 
 32. See J.E.M. Ag Supply, Inc. v. Pioneer Hi-Bred Int’l, Inc., 534 U.S. 124 (2001) 
(U.S.). See also Mark D. Janis & Jay P. Kesan, U.S Plant Variety Protection: Sound and 
Fury . . . ?, 39 HOUS. L. REV. 727, 728 (2002). 
 33. Infringement suits between right holders may be avoided in advance where cross-
licensing is adopted. 
 34. See Monsanto Canada, Inc. v. Schmeiser, [2004] 1 S.C.R. 902 (Can.). 
 35. Patent protection for isolated and purified genes was confirmed in the U.S. in the 
landmark case of Diamond v. Chakrabarty, which opened the gate for the development of 
the biotechnology industry. 447 U.S. 303 (1980) (U.S.). 
 36. Surinder Kaur Verma, Fitting Plant Variety Protection and Biotechnological 
Inventions in Agriculture Within the Intellectual Property Framework: Challenges for 
Developing Countries 8, UNCTAD/ICTSD/HKU/IDRC Regional Dialogue on Intellectual 
Property Rights (IPRs), Innovation and Sustainable Development (Nov. 8–10, 2004), 
available at http://www.iprsonline.org/resources/biotechnology.htm. 
 37. See Barbara Fleck & Claire Baldock, Intellectual Property Protection for Plant-
Related Inventions in Europe, 4 NATURE REVIEWS GENETICS 834, 836 (2003). 
 38. A patent generally entitles the owner to exclude third parties from making, using, or 
selling the invention under protection, while plant variety protection includes exclusive rights 
2012] Plant Variety Protection and Patent 133 
patent rights will unavoidably infringe the right in the plant variety and 
vice versa, in particular where the respective rights are owned by different 
right holders.
39
  Further, the scope of a patent over a new use of (or genetic 
material integral to) a certain plant variety is likely to embrace the whole, 
or a substantial part, of the protected variety.  This scenario is growing 
more likely as patent and plant variety protection expand their scopes to 
include similar or the same subject matters, and biotechnological science 
continues to advance.  
This possible conflict is unavoidable in virtually all jurisdictions 
unless the rights are exclusively regulated by separate laws.  Nonetheless, 
the adoption of separate laws alone is not adequate to address the problems 
in practice.  This can be discerned from the approaches adopted in Ethiopia 
and South Africa, which indicate the possibility of interface between the 
protection of patent and plant variety protection even where separate legal 
regimes are provided for the protection of the two subject matters.  Because 
of this unavoidable overlap, even with separate laws, compulsory cross-
licensing is a preferred approach in other jurisdictions such as the EU when 
the rights are held by different right holders. 
There also exists a concern that the existence of overlapping rights 
with different scopes of protection can have an adverse impact on food 
security and sustainable agriculture in developing and least developed 
countries.
40
  For instance, the limited exceptions to patent protection may 
hinder the farmers’ right to use the protected material, even if they are 
entitled to a saved seed exemption under the plant variety protection law.
41
  
Thus, farmers would be deprived of a privilege
42
 that is allowed under plant 
 
of producing or reproducing the variety, conditioning the variety for propagation, sale or 
marketing of the variety, and exporting or importing.  Moreover, plant variety protection 
includes broad exceptions (such as the farmers’ privilege to save seeds) that are not available 
against patents, which are broader in scope of protection, with limited exceptions. See, e.g., 
Patent Proc., supra note 16, arts. 22, 25; Plant Breeders’ Proc., supra note 16, arts. 5-7. 
 39. See Fleck & Baldock, supra note 37. 
 40. This is particularly a concern for African countries whose economies are primarily 
based on agriculture, because farmers need free access to seeds in order to guarantee food 
security in such countries.  For instance, “in Ethiopia, farmers contribute about 96 per cent 
of the annual seed requirement.” Cullet, supra note 1, at 106. 
 41. This may occur where patented genetic material forms part of seeds, so that using or 
reusing such seeds would amount to infringement of the patent.  There is no saved seed 
exemption under the Ethiopian patent law except in a limited case for acts done for non-
commercial purposes.  This exception does not include the right to sell or exchange the 
protected seeds to other farmers. Such an exemption exists under the EU Biotech Directive 
(Recital 47), while there is no exemption in the U.S. See, e.g., Monsanto Co. v. McFarling, 
302 F.3d 1291 (Fed. Cir. 2002) (U.S.). 
 42. The farmers’ privilege to use, share, save, and sell a protected plant variety does not 
extend to acts committed for commercial purposes.  In particular, farmers cannot sell farm-
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variety protection but prohibited under patent protection (except in case of 
personal use for noncommercial purposes),
43
 as long as the respective 
rights stem from the same subject matter.  In other words, the broader 
limitations and exceptions to the protection of plant varieties
44
 cannot be 
fully exploited without infringement of the concurrent utility patent (with a 
much broader scope of protection). This encumbrance can ultimately affect 
food security where the monopoly rights are created over food crops. 
 
B. Possible Solutions to the Interface Problem 
 
The intricate conflict of rights indicated above necessitates a clear 
solution.  One approach, which is followed by the European Union, is 
partly based on a compulsory cross-licensing scheme for cases where the 
respective rights cannot be acquired or exploited without infringing each 
other.
45
  This should not be confused with the benefit-sharing mechanisms 
adopted in South Africa and Ethiopia, which serve only to resolve the 
conflict of interests between right holders and the community that may 
arise in the context of biodiversity and genetic resource protection.  This 
approach is typical in cases of patent rights over biological resources, for 
which the patent holder is obliged to share the derived benefits with the 
concerned community.
46
  However, this does not address the interface 
between patent and plant variety protection in the course of their 
exploitation by the respective right holders.  Nor do the existing laws in 
these countries provide for a European-style cross-licensing scheme.  
Another approach—one that excludes the possible interface from the 
beginning—is a mutually exclusive system of protection under clearly 
delimited separate laws.  This approach, as adopted in countries like South 
Africa and Ethiopia, theoretically avoids the possible overlap between 
patent and plant variety rights.  However, these laws are not clear enough 
to avoid the problem in practice, taking into account possible future 
developments in patent and plant variety protection.  The overlap problem 
may be avoided only when the subject matters to which the rights attach are 
 
saved seeds or propagating material of a protected variety in the seed industry on a 
commercial scale.  See, e.g., Plant Breeders’ Proc., supra note 16, art. 6(2). 
 43. See Patent Proc., supra note 16, art. 25(1)(a). 
 44. See Janis & Kesan, supra note 32, at 751-52. 
 45. See Biotech Directive, supra note 19, art. 12. 
 46. It is important to note that the benefit sharing arrangement in South Africa is limited 
to the traditional knowledge contained in biodiversity, and does not extend to biological 
resources themselves. See Nadine Barron & Ed Couzens, Intellectual Property Rights and 
Plant Variety Protection in South Africa: An International Perspective, 16 J. ENVTL. L. 19, 
40 (2004). 
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specifically and exclusively regulated.  This may eventually entail the 
exclusion of one subject matter from being protected under the other legal 
regime except under its own category.  Alternatively, the creation of a prior 
right may exclude the subsequent creation of another right.  
Each of these solutions has its own merits and demerits, and each 
country’s approach should be adapted to its own needs and economic 
realities so as to achieve the objectives envisaged by both systems.  For 
instance, the exclusion of certain agricultural innovations from patent 
protection can avoid both the overlapping rights problem and the strong, 
broad monopoly rights inherent to patent protection which tend to limit 
farmers’ access to the products.  However, the exclusion will ultimately 
hamper the possible innovation in that sector which otherwise would be 
achieved via patent protection.  A less intrusive approach short of total 
exclusion may be achieved by adapting the farmers’ exemption under plant 
variety protection into the patent system.  The existing exception under 
Ethiopian patent law does not apparently embrace the farmers’ right to sell 
or exchange the protected product.
47
  A limited approach that resembles the 
exemption under plant variety protection has already been adopted in some 






The issue of overlap between plant variety and utility patent protection 
is becoming more critical than ever, with practical implications for the 
exploitation of the respective rights by different right holders.  The diverse 
approaches adopted worldwide often pose an interface problem, impeding 
harmonious exploitation of the rights.  Moreover, measures adopted by 
some countries to solve the problem are not clear and effective, and may 
hamper the protection and enforcement of the rights.  This may largely 
affect developing and least developed African countries like Ethiopia, 
which strive hard to achieve sustainable food security and agricultural 
development.  The problem may even raise concerns with regard to the 
mandates of member states to comply with the relevant international 
treaties.  
A well-designed sui generis system of plant variety protection with a 
clearly delineated scope is much more apt than a dual protection system in 
 
 47. The primary exception to patent holders’ rights under Ethiopian law is for “acts 
done for non-commercial purposes,” which would (arguably) not include selling the 
patented products to other farmers. Patent Proc., supra note 16, art. 25(1)(a). 
 48. See Fleck & Baldock, supra note 37. 
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countries where agriculture is the backbone of the economy.  For one thing, 
it is difficult to draw a bright line between the scopes of the different 
intellectual property rights, while it is much easier to provide for the clear, 
proper exclusion of certain subject matters from patent protection under the 
relevant patent law.  Additionally, patents over a plant varieties have the 
potential of diminishing or even denying farmers’ access to seeds or 
propagating material,
49
 while this need not be the case in sui generis 
systems.  The situation may be even more restrictive when the patent rights 
exist concurrently with plant variety protection over genetic resources.  
Nevertheless, the mere adoption of a sui generis system may not 
necessarily rule out the possible overlap between the rights of different 
rights holders.  Crafting a systematic approach such as compulsory cross-
licensing into the relevant laws is imperative to ensure effective 
exploitation of the rights with a view to promoting innovation and 
sustainable economic development.  To protect farmers, the farmers’ 
exemption under plant variety protection can be provided in the patent law 
as well for certain important subject matters.  In both cases, the approaches 




 49. See Phillip Cullet, supra note 1, at 108-09. 
